Bafna Pharmaceuticals Ltd

NSE: BAFNAPH · BSE: 532989 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹482.25
Market cap: ₹1,141 Cr
Revenue (annual): ₹150.6 Cr
Net profit (annual): ₹11.10 Cr
P/E (TTM): 99.1×Sector 43.8×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 9.34%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

11 Nov 2026 16:46 IST BSE

Financial ResultsAlfa Alert

Bafna Pharmaceuticals Q2 FY27 Results: Net Profit ₹6.8 Cr, Up 119.4% YoY

Bafna Pharmaceuticals' board approved unaudited financial results for the quarter and half year ended 30 September 2026, with a limited review report. Quarterly revenue from operations was ₹47.67 Crore, versus ₹35.47 Crore a year earlier.

Key figure: Net profit ₹6.8 Cr · +119.4% YoY

Open full results → Read the filing ↗

6 Nov 2026 15:20 IST BSE

Board Meeting Date

Bafna Pharmaceuticals Board Meeting Date

Bafna Pharmaceuticals will consider unaudited standalone quarterly results on 11 November 2026. Trading window stays closed until 13 November 2026.

Open announcement → Read the filing ↗